U.S. Markets closed

Genetic Technologies provides update on BREVAGen credentialing process

Genetic Technologies provided an update on BREVAGen sales and the "credentialing" process with the top ten U.S. Preferred Provider Organizations, or PPOs. To date, the Company has executed credentialing contracts with four PPOs which represents an estimated 13M covered lives in the U.S. Progress with these leadingPPOs has been a key driver of improved BREVAGen revenue collection.